Has control of hypercholesterolemia and hypertension in type 1 diabetes improved over time?

Diabetes Care

Volumn 28, Issue 3, 2005, Pages 521-526

  Zgibor, Janice C ^a,c   Wilson, Robb R ^b   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; DIABETES CONTROL; EXPERIENCE; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION;

ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MIDDLE AGED; PENNSYLVANIA; RETROSPECTIVE STUDIES;

EID: 14644419064     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.3.521     Document Type: Article

References (30)

1. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 7160:713-720, 1998
2. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339:1349-1357, 1998
3. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving H-H: Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int 60:277-283, 2001
4. Hypertension Study Group: Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Org 79:490-500, 2001
5. Hyman DJ, Pavlik VN: Characteristics of patients with uncontrolled hypertension in the United States. New Engl J Med 345:479-486, 2001
6. Collado-Mesa F, Colhoun HM, Stevens LK, Boavida J, Ferriss JB, Karamanos B, Kempler P, Michel G, Roglic G, Fuller JH, the EURODIAB IDDM Complications Study Group: Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study. Diabet Med 16:41-48, 1999
7. Ditusa L, Luzier AB, Jarosz DE, Snyder BD, Izzo JL: Treatment of hypertension in a managed care setting. Am J Man Care 7:520-524, 2001
8. Harris MI: Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23:754-758, 2000
9. McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Gizycki HV, Sowers JR: Control of cardiovascular risk factors in patients with diabetes and hypertension at Urban Academic Medical Centers. Diabetes Care 25:718-723, 2002
10. Pearson TA: The undertreatment of LDL-cholesterol: addressing the challenge. Int J Cardiol 74:S23-S28, 2000
11. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
12. Wagener DK, Sacks JM, LaPorte RE, MacGregor JM: The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 31:136-144, 1982
13. Zgibor JC, Songer TJ, Kelsey SF, Weissfeld J, Drash AL, Becker D, Orchard TJ: The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 23:472-476, 2000
14. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamler J: The hypertension detection and follow-up program. Prev Med 5:207-215, 1976
15. 1988 Joint National Committee: The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 148:1023-1038, 1988
16. Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 153:154-183, 1993
17. Warnick GR, Albers JJ: Heparin-MN(2+) quantitation of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 24:900-904, 1978
18. National Institutes of Health Department of Health Education and Welfare: Lipid Research Clinics Program. Washington, D.C., U.S. Government Printing Office, 1975
19. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
20. Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482, 1973
21. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
22. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 148:36-69, 1988
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
24. Early Treatment of Diabetic Retinopathy Study Coordinating Center: Manual of Operations. Baltimore, MD, University of Maryland School of Medicine, 1980
25. DCCT Research Group: Manual of Operations for the Diabetes Control and Complications Trial. Washington, D.C., U.S. Department of Commerce, 1987
26. Orchard TJ, Forrest KY-Z, Kuller LH, Becker DJ: Lipid and blood pressure treatment goals for type 1 diabetes. Diabetes Care 24:1053-1059, 2001
27. Stafford RS, Blumenthal D, Pasternak RC: Variations in cholesterol management practices of US Physicians. JACC 29:139-146, 1997
28. Zgibor JC, Songer TJ, Kelsey SF, Drash AL, Orchard TJ: Influence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 25:1584-1590, 2002
29. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 24 (Suppl. 1):S33-S43, 2001
30. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001